A GNAS gene mutation's independent expression in the growth of colorectal cancer: a systematic review and meta-analysis
HA Afolabi, SM Salleh, Z Zakaria, ES Ch'ng… - Cancers, 2022 - mdpi.com
Simple Summary Colorectal cancer progression involves multi-gene aberration of several
biomarkers via the downstream regulation of the MARK/ERK cascade. GNAS gene mutation …
biomarkers via the downstream regulation of the MARK/ERK cascade. GNAS gene mutation …
A Systematic Review and Meta‐analysis on the Occurrence of Biomarker Mutation in Colorectal Cancer among the Asian Population
H Afolabi, S Md Salleh, Z Zakaria… - BioMed Research …, 2022 - Wiley Online Library
Globally, colorectal carcinoma (CRC) is the third most common cancer and the third major
cause of cancer‐related death in both sexes. KRAS and BRAF mutations are almost …
cause of cancer‐related death in both sexes. KRAS and BRAF mutations are almost …
Associations of the 2018 World Cancer Research Fund/American Institute of Cancer Research (WCRF/AICR) cancer prevention recommendations with stages of …
AS Kværner, AR Andersen, HB Henriksen… - Cancer …, 2023 - Wiley Online Library
Background While adherence to cancer prevention recommendations is linked to lower risk
of colorectal cancer (CRC), few have studied associations across the entire spectrum of …
of colorectal cancer (CRC), few have studied associations across the entire spectrum of …
[HTML][HTML] Evaluating the clinical performance of a dual-target stool DNA test for colorectal cancer detection
Z Wang, J Shang, G Zhang, L Kong, F Zhang… - The Journal of Molecular …, 2022 - Elsevier
Previous work indicated that the dual-target stool DNA test, iColocomf, showed potential
utility for colorectal cancer (CRC) detection, but its clinical accuracy was not validated on …
utility for colorectal cancer (CRC) detection, but its clinical accuracy was not validated on …
NF-κB Activator 1 downregulation in macrophages activates STAT3 to promote adenoma-adenocarcinoma transition and immunosuppression in colorectal cancer
S Wang, Y Kuai, S Lin, L Li, Q Gu, X Zhang, X Li, Y He… - BMC medicine, 2023 - Springer
Background Adenoma-adenocarcinoma transition is a key feature of colorectal cancer
(CRC) occurrence and is closely regulated by tumor-associated macrophages (TAMs) and …
(CRC) occurrence and is closely regulated by tumor-associated macrophages (TAMs) and …
A non-aligned translation with a neoplastic classifier regularization to include vascular NBI patterns in standard colonoscopies
F Sierra-Jerez, F Martinez - Computers in Biology and Medicine, 2024 - Elsevier
Polyp vascular patterns are key to categorizing colorectal cancer malignancy. These
patterns are typically observed in situ from specialized narrow-band images (NBI) …
patterns are typically observed in situ from specialized narrow-band images (NBI) …
Blood-based biomarkers and novel technologies for the diagnosis of colorectal cancer and adenomas: a narrative review
D Magowan, M Abdulshafea, D Thompson… - Biomarkers in …, 2024 - Taylor & Francis
Aim: Blood-based biomarkers have shown promise for diagnosing colorectal cancer (CRC)
and adenomas (CRA). This review summarizes recent studies in this area. Methods: A …
and adenomas (CRA). This review summarizes recent studies in this area. Methods: A …
[HTML][HTML] Biofeedback therapy combined with Baduanjin on quality of life and gastrointestinal hormone level in patients with colorectal cancer
XD Zhou, HG Wei, FL Ai - World Journal of Gastrointestinal …, 2022 - ncbi.nlm.nih.gov
BACKGROUND With the change in people's lifestyles, the incidence of colorectal cancer
(CRC) is increasing. It is essential to study the efficacy of various treatment methods for CRC …
(CRC) is increasing. It is essential to study the efficacy of various treatment methods for CRC …
Targeted variant prevalence of FBXW7 gene mutation in colorectal carcinoma propagation. The first systematic review and meta-analysis
HA Afolabi, SM Salleh, Z Zakaria, NM Nafi, AABA Aziz… - Heliyon, 2024 - cell.com
ABSTRACT FBXW7 is a tumour suppressor gene that functions as E3-ubiquitin-ligase,
targeting numerous oncoproteins for degradation, ie, Cyclin-E, c-Myc, and Notch. FBXW7 …
targeting numerous oncoproteins for degradation, ie, Cyclin-E, c-Myc, and Notch. FBXW7 …
Establishment and validation of symptomatic patients colorectal screening score for predicting colorectal neoplasia risk
X Wang, X Zhang, J Liu, TY Liu… - Journal of Digestive …, 2023 - Wiley Online Library
Objectives Currently, most colorectal neoplasia (CRN) screening strategies target
asymptomatic individuals. However, studies on patients with non‐specific gastrointestinal …
asymptomatic individuals. However, studies on patients with non‐specific gastrointestinal …